Treatment of autoimmune hepatic diseases
Bueverov, A.O.
Klinicheskaia Meditsina 82(10): 62-66
2004
ISSN/ISBN: 0023-2149 PMID: 15584604 Document Number: 571843
The immunosuppresive drugs, primarily glucocorticosteroids, serve as the basis for the pathogenetic treatment of autoimmune diseases of the liver. In autoimmune hepatitis, immunosuppressive therapy induces and maintains persistent remission in most patients while in primary biliary cirrhosis and primary sclerosing cholangitis, its capacities are substantially limited. Ursodeoxycholic acid is used as the basic drug in predominantly occurring intrahepatic cholestasis. The treatment of cross autoimmune syndromes generally requires the choice of a combination of drugs.